ReP USP - Resultado da busca

Artigo de periodico
Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial (2022)
Mussi-Pinhata, Marisa Márcia ; Ward, Shawn; Laimon, Lauren; Pelton, Stephen I.; Canniff, Jennifer; Golner, Amanda; Bone, Frederic; Newton, Lassallete; Muresan, Petronella; Fenton, Terence; Johnson, Michael J.; João, Esau C.; Santos, Breno R.; Pilotto, Jose H.; Oliveira, Ricardo H.; Pinto, Jorge A.; Bó, Andrea G. B. L. Dal; Kreitchmann, Regis; Chakhtoura, Nahida; Duarte, Geraldo; Weinberg, Adriana
Fonte: Clinical Infectious Diseases. Unidade: FMRP
Assuntos: INFECÇÕES POR HIV, IMUNIZAÇÃO, GRAVIDEZ, IMUNOGENICIDADE DA VACINA, FARMACOTERAPIA, STREPTOCOCCUS PNEUMONIAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUSSI-PINHATA, Marisa Márcia et al. Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial. Clinical Infectious Diseases, v. 75, n. 6, p. 996-1005, 2022Tradução . . Disponível em: https://doi.org/10.1093/cid/ciac026. Acesso em: 03 nov. 2025.
APA
Mussi-Pinhata, M. M., Ward, S., Laimon, L., Pelton, S. I., Canniff, J., Golner, A., et al. (2022). Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial. Clinical Infectious Diseases, 75( 6), 996-1005. doi:10.1093/cid/ciac026
NLM
Mussi-Pinhata MM, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Muresan P, Fenton T, Johnson MJ, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Bó AGBLD, Kreitchmann R, Chakhtoura N, Duarte G, Weinberg A. Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial [Internet]. Clinical Infectious Diseases. 2022 ; 75( 6): 996-1005.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1093/cid/ciac026
Vancouver
Mussi-Pinhata MM, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Muresan P, Fenton T, Johnson MJ, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Bó AGBLD, Kreitchmann R, Chakhtoura N, Duarte G, Weinberg A. Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial [Internet]. Clinical Infectious Diseases. 2022 ; 75( 6): 996-1005.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1093/cid/ciac026
Artigo de periodico
Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV (2022)
Duarte, Geraldo ; Muresan, Petronella; Ward, Shawn; Laimon, Lauren; Pelton, Stephen I.; Canniff, Jennifer; Golner, Amanda; Bone, Frederic; Newton, Lassallete; Fenton, Terence; Coutinho, Conrado Milani; João, Esau C.; Santos, Breno R.; Pilotto, Jose H.; Oliveira, Ricardo H.; Pinto, Jorge A.; Machado, Elizabeth S.; Kreitchman, Regis; Chakhtoura, Nahida; Mussi-Pinhata, Marisa Márcia ; Weinberg, Adriana
Fonte: The Journal of Infectious Diseases. Unidade: FMRP
Assuntos: INFECÇÕES POR HIV, GRAVIDEZ, ANTICORPOS, CITOCINAS, POLISSACARÍDEOS BACTERIANOS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Geraldo et al. Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV. The Journal of Infectious Diseases, v. 225, n. 6, p. 1021-1031, 2022Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiab567. Acesso em: 03 nov. 2025.
APA
Duarte, G., Muresan, P., Ward, S., Laimon, L., Pelton, S. I., Canniff, J., et al. (2022). Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV. The Journal of Infectious Diseases, 225( 6), 1021-1031. doi:10.1093/infdis/jiab567
NLM
Duarte G, Muresan P, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Fenton T, Coutinho CM, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Machado ES, Kreitchman R, Chakhtoura N, Mussi-Pinhata MM, Weinberg A. Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV [Internet]. The Journal of Infectious Diseases. 2022 ; 225( 6): 1021-1031.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1093/infdis/jiab567
Vancouver
Duarte G, Muresan P, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Fenton T, Coutinho CM, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Machado ES, Kreitchman R, Chakhtoura N, Mussi-Pinhata MM, Weinberg A. Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV [Internet]. The Journal of Infectious Diseases. 2022 ; 225( 6): 1021-1031.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1093/infdis/jiab567
Artigo de periodico
Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial (2021)
Weinberg, Adriana; Muresan, Petronella; Laimon, Lauren; Pelton, Stephen I.; Goldblatt, David; Canniff, Jennifer; Zimmer, Bonnie; Bone, Frederic; Duarte, Geraldo; Mussi-Pinhata, Marisa Márcia
Fonte: The Lancet HIV. Unidade: FMRP
Assuntos: ANTI-HIV, ANTICORPOS, MÉTODO DUPLO-CEGO, INFECÇÕES POR HIV, VACINAS, GRAVIDEZ, STREPTOCOCCUS PNEUMONIAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEINBERG, Adriana et al. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. The Lancet HIV, v. 8, n. 7, p. e408–19, 2021Tradução . . Disponível em: https://doi.org/10.1016/S2352-3018(20)30339-8. Acesso em: 03 nov. 2025.
APA
Weinberg, A., Muresan, P., Laimon, L., Pelton, S. I., Goldblatt, D., Canniff, J., et al. (2021). Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. The Lancet HIV, 8( 7), e408–19. doi:10.1016/S2352-3018(20)30339-8
NLM
Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, Zimmer B, Bone F, Duarte G, Mussi-Pinhata MM. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial [Internet]. The Lancet HIV. 2021 ; 8( 7): e408–19.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S2352-3018(20)30339-8
Vancouver
Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, Zimmer B, Bone F, Duarte G, Mussi-Pinhata MM. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial [Internet]. The Lancet HIV. 2021 ; 8( 7): e408–19.[citado 2025 nov. 03 ] Available from: https://doi.org/10.1016/S2352-3018(20)30339-8
Artigo de periodico
Altered natural killerr cell function in HIV-exposed uninfected infants (2017)
Smith, Christiana; Jalbert, Emilie; Almeida, Volia de; Canniff, Jennifer; Lenz, Laurel L.; Mussi-Pinhata, Marisa Márcia; Cohn, Rachel A.; Yu, Qilu; Amaral, Fabiana R.; Pinto, Jorge; Alarcon, Jorge O.; Siberry, George; Weinberg, Adriana
Fonte: Frontiers in Immunology. Unidade: FMRP
Assuntos: HIV, INTERLEUCINAS, DOENÇAS INFECCIOSAS, DOENÇAS RESPIRATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMITH, Christiana et al. Altered natural killerr cell function in HIV-exposed uninfected infants. Frontiers in Immunology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.00470. Acesso em: 03 nov. 2025.
APA
Smith, C., Jalbert, E., Almeida, V. de, Canniff, J., Lenz, L. L., Mussi-Pinhata, M. M., et al. (2017). Altered natural killerr cell function in HIV-exposed uninfected infants. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.00470
NLM
Smith C, Jalbert E, Almeida V de, Canniff J, Lenz LL, Mussi-Pinhata MM, Cohn RA, Yu Q, Amaral FR, Pinto J, Alarcon JO, Siberry G, Weinberg A. Altered natural killerr cell function in HIV-exposed uninfected infants [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2025 nov. 03 ] Available from: https://doi.org/10.3389/fimmu.2017.00470
Vancouver
Smith C, Jalbert E, Almeida V de, Canniff J, Lenz LL, Mussi-Pinhata MM, Cohn RA, Yu Q, Amaral FR, Pinto J, Alarcon JO, Siberry G, Weinberg A. Altered natural killerr cell function in HIV-exposed uninfected infants [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2025 nov. 03 ] Available from: https://doi.org/10.3389/fimmu.2017.00470

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada